Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Change in Cash (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Change in Cash for 17 consecutive years, with $7.4 million as the latest value for Q1 2026.

  • Quarterly Change in Cash rose 2700.0% to $7.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $15.3 million through Mar 2026, up 128.62% year-over-year, with the annual reading at $8.2 million for FY2025, 389.62% up from the prior year.
  • Change in Cash for Q1 2026 was $7.4 million at Achieve Life Sciences, up from -$11.0 million in the prior quarter.
  • The five-year high for Change in Cash was $50.8 million in Q1 2024, with the low at -$51.6 million in Q2 2024.
  • Average Change in Cash over 5 years is -$868176.5, with a median of -$5.2 million recorded in 2023.
  • The sharpest move saw Change in Cash crashed 703.51% in 2024, then soared 2700.0% in 2026.
  • Achieve Life Sciences' Change in Cash stood at $6.6 million in 2022, then plummeted by 166.52% to -$4.4 million in 2023, then skyrocketed by 173.38% to $3.2 million in 2024, then tumbled by 442.82% to -$11.0 million in 2025, then surged by 166.94% to $7.4 million in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Change in Cash are $7.4 million (Q1 2026), -$11.0 million (Q4 2025), and -$19.9 million (Q3 2025).